ycec(SH:600248)2022-04-27 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥33,499,786,085.66, representing a year-on-year increase of 10.14%[6] - The net profit attributable to shareholders of the listed company was ¥770,207,310.44, reflecting a growth of 4.12% compared to the same period last year[6] - The net cash flow from operating activities increased significantly by 361.05%, amounting to ¥516,053,010.45[6] - The basic earnings per share decreased by 10.65% to ¥0.2088[6] - The total operating revenue for Q1 2022 was CNY 33,499,786,085.66, an increase of 10.4% compared to CNY 30,414,766,646.61 in Q1 2021[27] - The net profit for Q1 2022 reached CNY 895,324,035.76, compared to CNY 749,299,228.73 in Q1 2021, representing a year-over-year increase of 19.5%[31] - The profit attributable to shareholders of the parent company was CNY 770,207,310.44 in Q1 2022, compared to CNY 739,718,184.23 in Q1 2021, indicating a growth of 4.1%[32] - The total comprehensive income attributable to the parent company's shareholders was CNY 867,578,174.18 in Q1 2022, compared to CNY 752,738,756.99 in Q1 2021, an increase of 15.2%[32] Assets and Liabilities - Total assets at the end of the reporting period were ¥230,880,281,643.50, a slight increase of 0.71% from the end of the previous year[8] - The company's current assets totaled CNY 204,173,244,261.79, compared to CNY 202,512,106,343.77 in the previous year[21] - The company's total liabilities were CNY 188,218,522,694.85, slightly down from CNY 188,823,469,807.67[25] - The total liabilities amounted to CNY 206,757,850,066.52, slightly up from CNY 206,105,296,641.75 in the previous year[27] - The total equity increased to CNY 24,122,431,576.98 from CNY 23,149,181,682.36, marking a growth of 4.2%[27] Cash Flow - In Q1 2022, the company's operating cash inflow totaled CNY 35,888,890,690.90, an increase of 6.6% from CNY 33,665,431,626.88 in Q1 2021[37] - The net cash flow from operating activities was CNY 516,053,010.45, a significant recovery from a negative CNY 197,687,363.05 in the same period last year[37] - The company reported cash outflows from investing activities of CNY 155,863,579.66, a decrease from CNY 698,191,860.18 in Q1 2021[39] - The net cash flow from financing activities was CNY 1,248,279,943.74, compared to CNY 257,355,480.82 in Q1 2021, indicating a strong increase in financing[39] - The total cash and cash equivalents at the end of Q1 2022 reached CNY 18,212,659,750.82, up from CNY 14,868,096,487.46 at the end of Q1 2021[39] Expenses - Research and development expenses increased by 25.97%, indicating a rise in investment in scientific research projects[12] - The company reported a 32.51% increase in selling expenses due to business expansion of subsidiaries[12] - The total operating costs for Q1 2022 were CNY 32,289,513,719.64, up from CNY 29,538,166,786.74 in Q1 2021, reflecting a growth of 9.3%[27] - The company reported a decrease in tax expenses to CNY 105,196,018.84 from CNY 124,030,831.40 in the previous year, a reduction of 15.2%[31] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 61,015[16] - The equity attributable to shareholders of the listed company rose by 4.56% to ¥19,438,131,044.24[8] Other Information - The company has not disclosed any significant new product developments or market expansion strategies in the current report[19] - The company experienced a foreign exchange loss of CNY 7,461,267.86, contrasting with a gain of CNY 3,941,369.20 in the previous year[39]